MT Newswires Live2024-10-29
Tong Ren Tang Technologies (HKG:1666) recorded net profit attributable to shareholders of 546.4 million yuan and operating revenue of about 5.48 billion yuan for the nine months ended Sept. 30, a Tuesday Hong Kong bourse filing said.
The detailed financial results of the pharmaceutical company will be disclosed in the unaudited third quarterly results for the nine months of the company's controlling shareholder, Beijing Tong Ren Tang.
Price (HKD): $5.34, Change: $-0.050, Percent Change: -0.93%
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.
Range Resources Shares Down 1% in Relatively Light Volume After the Bell Following Results
Apollo, Blackstone Lead $4 Billion Loan for Boeing Unit Takeover- Bloomberg News
Rpt-Sap Se - Continues to Expect Current Cloud Backlog Growth at Constant Currencies to Slightly Decelerate in 2025.
Rpt-Sap Se - Sees FY EUR 33.1 - 33.6 Bln Cloud and Software Revenue at Constant Currencies
Rpt-Sap Q1 Adjusted Free Cash Flow EUR 3,583 Million